InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Discover the complete record of transactions filed by WAGNER CHARLES F JR, Chief Financial Officer. Director active across 1 companies, notably Vertex Pharmaceuticals INC / MA. Cumulatively, 11 filings have been logged. Total volume traded: €781k. The latest transaction was filed on 2 May 2022 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations11 total
€4,85020 shares@ €242.52410.0000% mcap0.2% of flow
Common Stock
SEC:0000899243-22-016635:0·
€143,814547 shares@ €262.91380.0001% mcap5.2% of flow
Common Stock
SEC:0000899243-22-016318:0·
€70,830300 shares@ €236.10150.0001% mcap2.6% of flow
Common Stock
SEC:0000899243-22-013708:0·
€705,7773,110 shares@ €226.9380.0006% mcap25.5% of flow
Common Stock
SEC:0000899243-22-011703:0·
€441,1812,189 shares@ €201.54450.0004% mcap15.9% of flow
Common Stock
SEC:0000899243-22-008128:0·
€702,9303,439 shares@ €204.39950.0006% mcap25.4% of flow
Common Stock
SEC:0000899243-22-007217:0·
€506,6392,434 shares@ €208.15090.0005% mcap18.3% of flow
Common Stock
SEC:0001209191-22-009252:0·
03,698 shares0
Common Stock
SEC:0001209191-22-006796:0·
03,698 shares0
Common Stock
SEC:0001209191-22-006796·
€97,974547 shares@ €179.1114100.0% of flow
Common Stock
SEC:0001209191-21-030524·
€97,974547 shares@ €179.11140.0001% mcap3.5% of flow
Common Stock
SEC:0001209191-21-030524:0·
11 of 11 declarations
About WAGNER CHARLES F JR
Charles F. Wagner Jr is Executive Vice President and Chief Financial Officer at Vertex Pharmaceuticals Inc. He oversees the financial operations of the company, ensuring effective resource management and contributing to financial strategy. His role is essential for the financial health of the organization.
